Akanda Corp
NASDAQ:AKAN
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| UK |
A
|
Akanda Corp
NASDAQ:AKAN
|
2.4m USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
973.3B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
284.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.3B USD |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.3B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.8B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.5B USD |
Loading...
|
Market Distribution
| Min | -188 120% |
| 30th Percentile | 0% |
| Median | 0% |
| 70th Percentile | 0.1% |
| Max | 10 443.9% |
Other Profitability Ratios
Akanda Corp
Glance View
Akanda Corp. engages in cultivating cannabis. The firm is engaged in the cultivation, manufacturing, and distribution of cannabis. The firm cultivate and process natural cannabis at its facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower and cannabis concentrates to wholesalers in international markets. The firm also import and sell medical cannabis-based products to the domestic market in the United Kingdom. The Company’s subsidiaries include Bophelo Bio Science and Wellness (Pty) Limited, Canmart Limited, Bophelo Holdings Limited, and Cannahealth Limited. Bophelo Bio Science and Wellness (Pty) Limited is focused on the cultivation of cannabis, the production of medical cannabis products including dried flower, oils, and other concentrates. Canmart Limited is engaged in the production and sale of cannabis-based products for medicinal use.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Akanda Corp is -489.5%, which is above its 3-year median of -1 955%.
Over the last 1 years, Akanda Corp’s Net Margin has increased from -1 494.1% to -489.5%. During this period, it reached a low of -3 881.2% on Jun 30, 2024 and a high of -489.5% on Jan 31, 2025.
